Health Trials

Serratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardiac Surgery

ConditionsHeart Valve DiseasePostoperative Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

About this trial

This randomized, double-blind, placebo-controlled study aims to evaluate the effect of the serratus posterior superior intercostal plane (SPSIP) block on postoperative pain and opioid consumption in patients undergoing minimally invasive cardiac valve surgery via mini-thoracotomy.

Eligibility criteria

Qualifiers

Adult patients aged 18-75 years

ASA physical status I-III

Scheduled for elective minimally invasive cardiac valve surgery via mini-thoracotomy

Able to understand and use the Numeric Rating Scale (NRS)

Disqualifiers

Age >75 years

Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine)

Coagulopathy or ongoing anticoagulant therapy that cannot be discontinued

Infection at the planned block site

Trial design

Treatments tested in this trial

  • Serratus Posterior Superior Intercostal Plane Block With Bupivacaine
  • Serratus Posterior Superior Intercostal Plane Block With Saline

Treatment groups

90 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Lead sponsor

Source ClinicalTrials.gov